Michal Rose

Michal Rose, MD, is a Professor at Yale School of Medicine and holds dual leadership roles as Director of the VA Comprehensive Cancer Center and Chief of Veterans Affairs in Medical Oncology and Hematology. She is affiliated with Yale Cancer Center, Yale Ventures, and multiple departments including Internal Medicine, Cancer Prevention and Control, and Developmental Therapeutics. Her work bridges academic medicine and veterans' healthcare through multidisciplinary collaborations.

Education includes:

• MD from Hebrew University (1987)
• Residency in Internal Medicine at Hadassah Hospital Mount Scopus (1993)
• Fellowship in Hematology & Oncology at Yale University (1996)
• Residency in Internal Medicine at Yale University (1999)

Dr. Rose's research focuses on oncology, hematology, and health services for veterans. Key interests include:

• Health Services Research: Optimizing cancer care delivery in VA systems
• Hematology/Oncology: Myelodysplastic syndromes, thrombophilia, and leukemia
• Cancer Prevention: Lung cancer screening adherence and disparities
• Clinical Guidelines: Developing ASCO/NCCN protocols for liver cancer and leukemia
• Veterans Health: Addressing unique cancer care challenges in military populations

Her publications emphasize practical clinical applications, with recent work on hepatocellular carcinoma guidelines, lung cancer screening efficacy in veterans, and electronic hematology consultation models. Research trends show consistent focus on improving diagnostic pathways, therapeutic protocols, and equitable healthcare access.

Dr. Rose leads multidisciplinary teams at the VA Connecticut Healthcare System and collaborates extensively with Yale Cancer Center and Smilow Cancer Hospital. She has been featured on Yale Cancer Answers discussing veteran-centric oncology care innovations.